Site Search
Professionals 261 results
Capabilities 63 results
Practice Area
Winston’s Debt Finance team focuses on all aspects of leveraged finance and asset-based lending both internationally and domestically. Our clients include leading international investment banks, commercial banks, direct lenders, credit funds, insurance companies, CLOs, and other institutional investors, as well as private equity funds, hedge funds, and corporations.
Practice Area
Keeping a deal moving forward can be challenging. Our 100+ Finance attorneys help clients maintain momentum with a commitment to understanding the challenges, risks, and opportunities they face. Our global team has developed great insights through the representation of financial institutions and corporate enterprises of all types and sizes in the finance industry. We have a well-rounded finance practice, with dedicated teams that advise banks, credit funds, alternative capital providers, sponsors, and corporations on a wide range of transactions including debt finance (leveraged, asset-based, and reserve-based lending), fund finance, structured finance, derivatives and structured products, project finance, and transportation finance.
Industry
The medical device industry is currently undergoing monumental change—from supply chain challenges to disruptive technologies and economic fluctuations. To pave the way for a more accessible and innovative healthcare landscape—including advances in wearables, implants, diagnostics, mobility, drug delivery—the evolving and expansive medical device industry faces wide-ranging legal needs. Clients in this sector can tap the remarkable depth and breadth of our sector-focused and skilled attorneys in the U.S. and abroad. Our Healthcare & Life Sciences Industry Group engages clients at all points in the product development life cycle to provide sound advice and practical solutions regardless of the client’s size or the complexity of their need. We help clients navigate today’s complex regulatory landscape, defend products and reputations in the face of high-profile product liability and mass tort claims, protect innovative intellectual property (IP), and leverage cross-border experience to advise on commercial transactions.
Experience 242 results
Experience
|February 22, 2026
Winston & Strawn LLP Paris advised the Compagnie Européenne de Garantie et Caution (CEGC, BPCE Group) financial creditors on the adoption of Réalités’ recovery plan by the Nantes Commercial Court.
Experience
|February 6, 2026
Winston Represented ETi Gida in Acquisition of TRUBAR
A Winston deal team, led by Tim Kincaid, Brad Vaiana and Ben Popeck, represented Turkish snack company ETI Gida Sanayi ve Ticaret Anonim Sirketi (ETi Gida) in its acquisition of Miami-based TRUBAR, a popular nutrition bar known for dessert-inspired flavor and clean ingredients.
Experience
|January 22, 2026
Advised SQM on US$600M offering of subordinated capital notes due 2056 (Hybrid Bond Offering)
Winston & Strawn LLP advised longstanding client Sociedad Química y Minera de Chile S.A. (“SQM”) (NYSE: SQM) on its US$600 million offering of subordinated capital notes. The notes were offered in the United States pursuant to Rule 144A and outside the United States pursuant to Regulation S.The subordinated capital notes are due in 2056 and constitute SQM’s first international hybrid bond issuance, structured to be consistent with SQM’s recent UF 10 million (approximately US$ 430 million) Series S hybrid-subordinated bond issuance in the Chilean securities market. The notes bear an initial annual interest rate of 5.625% and are subject to reset on April 22, 2031 (the “First Reset Date”), and on every fifth anniversary thereafter, based on a spread over the 5-year U.S. Treasury bond rate, with interest rate step-ups on the fifth and twentieth anniversaries of the First Reset Date. The transaction closed on January 22, 2026.BofA Securities, Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Santander US Capital Markets LLC, and Scotia Capital (USA) Inc. acted as initial purchasers of the notes.Link Capital Partners was financial advisor to SQM.SQM is a global company with a leading position in the lithium, iodine, and potassium nitrate markets. It develops and produces a diverse range of products for industries essential to human progress, including health, nutrition, renewable energy, and technology, driven by innovation and technological development.The Winston & Strawn team advising on the transaction included corporate partner Sey-Hyo Lee (New York) and foreign legal advisor Bruno M. Fiorino (New York). Partner Katherine Erbeznik (New York) advised on tax matters.
Insights & News 2,729 results
Non-Fungible Insights: Blockchain Decrypted
|March 13, 2026
|7 Min Read
The close of 2025 highlighted the continuing momentum for the digital asset industry, with regulatory developments accelerating rather than slowing.
Recognitions
|March 11, 2026
|1 Min Read
Michael J. Blankenship Ranked #1 Top DeSPAC Lawyer in North America by MergerLinks for FY 2025
Winston & Strawn partner Michael J. Blankenship has been ranked #1 Top DeSPAC Lawyer in North America for FY 2025 by MergerLinks, according to its latest league tables recognizing leading advisers in the global M&A market.
MaritimeFedWatch
|March 10, 2026
|4 Min Read
Jones Act waiver possibilities appear in the news pretty much every time there is a spike in the price of fuel in the United States. Sure enough, there are reports that the Trump Administration is considering waiving the Jones Act in connection with the Middle East war.
Other Results 63 results
Law Glossary
What Is Performance-Based Compensation?
Performance-based compensation (PBC) is a system for rewarding employees financially, outside of their regular salaries. The financial compensation is based on how individual employees, departments, the company, or the company’s stock price performs during a specific time frame and in accordance with pre-determined goals set by the organization. These programs may also be called Pay-For-Performance systems. Companies who utilize these systems must be prepared to define and track performance, as well as provide compensation, such as bonuses, when objectives are met according to benchmarks. The supplemental income will also have tax implications for employees.
Law Glossary
How Does an Applicant Establish Biosimilarity?
An applicant typically demonstrates biosimilarity based on non-clinical analyses that focus on the structure and functional differences between the biosimilar and reference product.
Site Content
What Is the Better Business Bureau (BBB)?
The Better Business Bureau (BBB) is a private organization that provides the public with information on businesses and charities. It also handles consumer complaints about firms. The nonprofit bureau has developed a rating system for businesses based on a scale of A+ to F. Each rating is determined according to specific criteria relating to a company’s ethics and performance. The BBB offers guidance to companies on proper practices. Firms that follow these policies and pay annual dues can become accredited through the bureau. To obtain accreditation, a business must be operate with transparency, be appropriately licensed, adhere to BBB advertising codes, and have no unresolved consumer complaints.